Treatment of intermediate-risk prostate cancer with active surveillance in the routine care—Long-term outcomes of a prospective noninterventional study (HAROW)
- DOI
- 10.1097/cu9.0000000000000203
- Published
- 2023-04-20
- Container
- Current Urology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/cu9.0000000000000203,
title = {Treatment of intermediate-risk prostate cancer with active surveillance in the routine care—Long-term outcomes of a prospective noninterventional study (HAROW)},
author = {Lothar Weissbach and Andreas Schwarte and Edith A. Boedefeld and Jan Herden},
year = {2023},
journal = {Current Urology},
doi = {10.1097/cu9.0000000000000203},
url = {https://doi.org/10.1097/cu9.0000000000000203}
}RIS
TY - JOUR TI - Treatment of intermediate-risk prostate cancer with active surveillance in the routine care—Long-term outcomes of a prospective noninterventional study (HAROW) AU - Lothar Weissbach AU - Andreas Schwarte AU - Edith A. Boedefeld AU - Jan Herden PY - 2023 JO - Current Urology DO - 10.1097/cu9.0000000000000203 UR - https://doi.org/10.1097/cu9.0000000000000203 ER -
APA
Weissbach, L., Schwarte, A., Boedefeld, E. A., & Herden, J. (2023). Treatment of intermediate-risk prostate cancer with active surveillance in the routine care—Long-term outcomes of a prospective noninterventional study (HAROW). Current Urology. https://doi.org/10.1097/cu9.0000000000000203
Source records
- crossref · retrieved 2026-09-27T11:05:38.053Z